Entelos and Novartis enter into research collaboration
Under the terms of the agreement, Novartis will provide R&D funding and Entelos will conduct biosimulation research using its PhysioLab platforms, which predict the effects of drugs using
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.